Secondary cytoreduction in epithelial ovarian cancer

Mark A. Morgan; Stephen C. Rubin

doi:10.1016/1040-8428(94)00111-6

Secondary cytoreduction in epithelial ovarian cancer

Mark A. Morgan
, Stephen C. Rubin

Surgery

Gynecology University

Research output: Contribution to journal › Review article › peer-review

16 Scopus citations

Original language	English
Pages (from-to)	1-8
Number of pages	8
Journal	Critical Reviews in Oncology/Hematology
Volume	18
Issue number	1
DOIs	https://doi.org/10.1016/1040-8428(94)00111-6
State	Published - Jan 1995

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

SDG 3 Good Health and Well-being

Keywords

Actuarial Analysis
Antineoplastic Agents/administration & dosage
Chemotherapy, Adjuvant
Clinical Trials as Topic
Combined Modality Therapy
Female
Humans
Infusions, Parenteral
Laparotomy
Multicenter Studies as Topic
Neoplasm Recurrence, Local
Ovarian Neoplasms/drug therapy
Phosphorus Radioisotopes/therapeutic use
Radiotherapy, Adjuvant
Randomized Controlled Trials as Topic
Reoperation
Salvage Therapy
Survival Analysis
Treatment Outcome

Access to Document

10.1016/1040-8428(94)00111-6

Cite this

@article{bbddec2401804ff58181dd40b7656e8c,

title = "Secondary cytoreduction in epithelial ovarian cancer",

keywords = "Actuarial Analysis, Antineoplastic Agents/administration \& dosage, Chemotherapy, Adjuvant, Clinical Trials as Topic, Combined Modality Therapy, Female, Humans, Infusions, Parenteral, Laparotomy, Multicenter Studies as Topic, Neoplasm Recurrence, Local, Ovarian Neoplasms/drug therapy, Phosphorus Radioisotopes/therapeutic use, Radiotherapy, Adjuvant, Randomized Controlled Trials as Topic, Reoperation, Salvage Therapy, Survival Analysis, Treatment Outcome",

author = "Morgan, \{Mark A.\} and Rubin, \{Stephen C.\}",

year = "1995",

month = jan,

doi = "10.1016/1040-8428(94)00111-6",

language = "English",

volume = "18",

pages = "1--8",

journal = "Critical Reviews in Oncology/Hematology",

issn = "1040-8428",

publisher = "Elsevier Ireland Ltd",

number = "1",

}

TY - JOUR

T1 - Secondary cytoreduction in epithelial ovarian cancer

AU - Morgan, Mark A.

AU - Rubin, Stephen C.

PY - 1995/1

Y1 - 1995/1

KW - Actuarial Analysis

KW - Antineoplastic Agents/administration & dosage

KW - Chemotherapy, Adjuvant

KW - Clinical Trials as Topic

KW - Combined Modality Therapy

KW - Female

KW - Humans

KW - Infusions, Parenteral

KW - Laparotomy

KW - Multicenter Studies as Topic

KW - Neoplasm Recurrence, Local

KW - Ovarian Neoplasms/drug therapy

KW - Phosphorus Radioisotopes/therapeutic use

KW - Radiotherapy, Adjuvant

KW - Randomized Controlled Trials as Topic

KW - Reoperation

KW - Salvage Therapy

KW - Survival Analysis

KW - Treatment Outcome

UR - https://www.scopus.com/pages/publications/0028896420

UR - https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=purepublist2023&SrcAuth=WosAPI&KeyUT=WOS:A1995QT99900001&DestLinkType=FullRecord&DestApp=WOS

U2 - 10.1016/1040-8428(94)00111-6

DO - 10.1016/1040-8428(94)00111-6

M3 - Review article

C2 - 7695822

SN - 1040-8428

VL - 18

SP - 1

EP - 8

JO - Critical Reviews in Oncology/Hematology

JF - Critical Reviews in Oncology/Hematology

IS - 1

ER -

Secondary cytoreduction in epithelial ovarian cancer

UN SDGs

Keywords

Access to Document

Other files and links

Fingerprint

Cite this